Structure Therapeutics Inc. (GPCR)
NASDAQ·Healthcare·Biotechnology
$42.93
-0.70%
Mkt Cap $3.25B
Analyst Ratings
No recent rating data.
Price Target (14 analysts)
$116.71
Range $90.00 – $145.00
Implied Upside
+171.9%
Consensus $116.71 vs current $42.93